# MAYD Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mayd-group

- Industry: Consumer Services
- Headquarters: Berlin, Germany
- Website: www.getmayd.com
- Total disclosed funding: $49M
- Latest round: Series A (Feb 11, 2022)
- Investors on record: 4

## About

MAYD Group GmbH, based in Berlin, Germany, specializes in rapid medication delivery, catering to the increasing demand for efficiency in healthcare solutions by ensuring medications are delivered within 30 minutes to customers' locations.MAYD Group GmbH operates in the healthcare sector, focusing on the expedited delivery of pharmaceuticals. Founded in 2021 in Berlin, Germany, by Hanno Heintzenberg and Lukas Pieczonka, the company has completed a total of 3 deals. The most recent funding round, a Series A, occurred on June 19, 2024, raising EUR 30.000 mn, led by Lightspeed Venture Partners along with other investors such as 468 Capital, Earlybird Venture Capital, and Target Global. The total amount raised to date is EUR 30.000 mn, with a current company valuation of EUR 158.284 mn.MAYD specializes in the rapid delivery of medications, aiming to address increasing consumer demand for efficiency in healthcare solutions. The company guarantees medication delivery within 30 minutes, catering to individuals with urgent medical needs and those who prefer the convenience of receiving medications directly at their location. This service alleviates the waiting times typically associated with traditional pharmacy visits, enhancing the overall customer experience. MAYD currently operates in several urban areas that demonstrate high demand for quick pharmaceutical services, ensuring accessibility to a broad spectrum of users seeking prompt healthcare solutions.MAYD generates revenue through a direct-to-consumer model, where customers place orders for medications via the company’s online platform or mobile application. Customers pay for medications at the time of order, with pricing plans reflecting the urgency and convenience of the service, including potential delivery fees. In addition, MAYD may establish partnerships with healthcare providers and insurance companies to facilitate seamless medication access for patients, enhancing both reach and customer satisfaction. The company's flagship service—the 30-minute medication delivery—positions it competitively within the pharmaceutical market, capitalizing on the trend of immediate healthcare access.As of June 19, 2024, MAYD Group GmbH filed for bankruptcy protection, which significantly impacts its future growth strategy. While previous plans included expanding into new markets and launching additional products, the current financial situation may hinder these initiatives. The recent Series A funding was intended to support growth and expansion, yet the filing for bankruptcy protection creates uncertainty around the execution of these plans.

## Funding rounds

- Series A, Feb 11, 2022, $34M — Lightspeed Venture Partners, Earlybird, Target Global, 468 Capital
- Seed, Apr 30, 2021, $15M — Earlybird, Target Global, 468 Capital

## Investors

- Earlybird (https://capitalatlas.ai/funds/earlybird) — Seed, Series A
- Target Global (https://capitalatlas.ai/funds/target-global) — Seed, Series A
- 468 Capital (https://capitalatlas.ai/funds/468-capital) — Seed, Series A
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series A